Pascal Laeng

Pascal Laeng, Ph.D.

Program Manager

Dr. Pascal Laeng joined in April 2015 the National Institute of Neurological Disorders and Stroke (NINDS) in the Office of Translational Research. He serves as a Scientific Project Manager for the Blueprint Neurotherapeutics Network (BPN). Dr. Laeng has more than twenty years of research experience, and fourteen years of experience in CNS drug discovery and early development in the biotech industry. Prior to joining NIH, Dr. Laeng has held senior management positions at Psychiatric Genomics Inc. (MD) and Galenea Corp. (Cambridge, MA) supervising in vitro pharmacology groups and leading multidisciplinary drug discovery teams from early Target Discovery to late Lead Optimization stages. Dr. Laeng worked in several CNS therapeutic areas including schizophrenia, cognitive deficits, bipolar disorder, depression, multiple sclerosis, obesity, and neurogenesis. Dr. Laeng received his Ph.D. in Neurobiology at the University of Louis Pasteur (Strasbourg, France). He completed postdoctoral training at the Swiss Federal Institute of Technology (Zurich, ETH) in Pr. Melitta Schachner’s laboratory, and at NIH (Bethesda) in the groups of Dr. Ronald McKay (NINDS) and Dr. Charles Gerfen (National Institute of Mental Health, NIMH). Dr. Laeng also has extensive scientific expertise in phenotypic screening, cell-based assays, system biology, stem cell biology and in vitro pharmacology.